Clinical Research Division, Fred Hutch
Dr. Stacey Cohen studies the influence of genetics on high-risk gastrointestinal cancers and cancer treatment. One of her main research interests is inherited genetic syndromes, such as Lynch syndrome, that put people at high risk of developing colorectal cancer. As a clinician, she cares for such individuals as well as patients with colorectal, pancreatic, liver or other gastrointestinal cancers.
Assistant Professor, Division of Oncology
University of Washington
Brandeis University, 2004, B.S. (Biology)
University of Michigan, 2008, M.D.
Colorectal cancer high-risk genetic syndromes
Tumor mutation profiling
The influence of germline genetics on cancer outcomes and prediction of treatment benefit
Assessment of candidate genes that may affect likelihood of progression of early cancers to advanced or metastatic disease
Use of next-generation sequencing tumor and germline genetics assays to determine new biomarkers
Evaluation of the CpG Island Methylator Phenotype (CIMP) as a prognostic and predictive biomarker
Characterization of Familial Colorectal Cancer Type X
Tumor organoid development to test patient-specific drug responses